To the Editor The transparency of clinical trial data and its timely dissemination remains critical. We read with interest the article by Sreekrishnan et al1 that assessed the publication rates and time to publication of all the closed neurology interventional clinical trials that were registered in ClinicalTrials.gov. We congratulate the authors and take this opportunity to highlight a few concerns for further clarification.
Malhotra K, Rayi A, Liebeskind DS. Reporting and Dissemination of Clinical Trials in Neurology. JAMA Neurol. 2018;75(12):1573. doi:10.1001/jamaneurol.2018.3306
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: